-
公开(公告)号：US07226950B2
公开(公告)日：2007-06-05
申请号：US11500078
申请日：2006-08-07
IPC分类号： A61K31/135 , C07C211/03
CPC分类号： C07D213/30 , A61K31/135 , A61K31/401 , A61K31/4152 , A61K31/417 , A61K31/4184 , A61K31/4402 , A61K31/4465 , A61K31/5375 , C07C217/08 , C07C217/30 , C07C217/36 , C07C217/76 , C07C217/84 , C07C255/54 , C07C2601/18 , C07C2602/10 , C07D207/09 , C07D211/26 , C07D213/38 , C07D213/65 , C07D215/20 , C07D233/56 , C07D233/64 , C07D235/06 , C07D295/13 , C07D317/54 , C07D333/16
摘要： The invention provides sodium channel modulating compounds which are useful for treating diseases or conditions associated with sodium channel activity, such as neuropathic pain. The invention also provides pharmaceutical compositions comprising a compound of the present invention, as well as therapeutic methods comprising administering such a compound or salt to a mammal (e.g. a human).
摘要翻译： 本发明提供了钠通道调节化合物，其可用于治疗与钠通道活性相关的疾病或病症，例如神经性疼痛。 本发明还提供包含本发明化合物的药物组合物，以及包括向哺乳动物（例如人）施用此类化合物或盐的治疗方法。
-
公开(公告)号：US07132422B2
公开(公告)日：2006-11-07
申请号：US11052504
申请日：2005-02-04
IPC分类号： A61K31/5375 , A61K31/40 , C07D265/30 , C07D207/04
CPC分类号： C07D213/30 , A61K31/135 , A61K31/401 , A61K31/4152 , A61K31/417 , A61K31/4184 , A61K31/4402 , A61K31/4465 , A61K31/5375 , C07C217/08 , C07C217/30 , C07C217/36 , C07C217/76 , C07C217/84 , C07C255/54 , C07C2601/18 , C07C2602/10 , C07D207/09 , C07D211/26 , C07D213/38 , C07D213/65 , C07D215/20 , C07D233/56 , C07D233/64 , C07D235/06 , C07D295/13 , C07D317/54 , C07D333/16
摘要： The invention provides sodium channel modulating compounds which are useful for treating diseases or conditions associated with sodium channel activity, such as neuropathic pain. The invention also provides pharmaceutical compositions comprising a compound of the present invention, as well as therapeutic methods comprising administering such a compound or salt to a mammal (e.g. a human).
-
公开(公告)号：US06872741B2
公开(公告)日：2005-03-29
申请号：US10659931
申请日：2003-09-11
IPC分类号： A61K31/135 , A61K31/401 , A61K31/4152 , A61K31/417 , A61K31/4184 , A61K31/4402 , A61K31/4465 , A61K31/5375 , A61P25/00 , C07C217/08 , C07C217/30 , C07C217/36 , C07C217/76 , C07C217/84 , C07C255/54 , C07D207/09 , C07D211/26 , C07D213/30 , C07D213/38 , C07D213/65 , C07D215/20 , C07D231/12 , C07D233/54 , C07D233/61 , C07D233/76 , C07D235/06 , C07D295/13 , C07D317/54 , C07D333/16 , A61K31/415 , A61K31/4164 , C07D231/10
CPC分类号： C07D213/30 , A61K31/135 , A61K31/401 , A61K31/4152 , A61K31/417 , A61K31/4184 , A61K31/4402 , A61K31/4465 , A61K31/5375 , C07C217/08 , C07C217/30 , C07C217/36 , C07C217/76 , C07C217/84 , C07C255/54 , C07C2601/18 , C07C2602/10 , C07D207/09 , C07D211/26 , C07D213/38 , C07D213/65 , C07D215/20 , C07D233/56 , C07D233/64 , C07D235/06 , C07D295/13 , C07D317/54 , C07D333/16
摘要： The invention provides sodium channel modulating compounds which are useful for treating diseases or conditions associated with sodium channel activity, such as neuropathic pain. The invention also provides pharmaceutical compositions comprising a compound of the present invention, as well as therapeutic methods comprising administering such a compound or salt to a mammal (e.g. a human).
-
公开(公告)号：US06646012B2
公开(公告)日：2003-11-11
申请号：US10050696
申请日：2002-01-15
IPC分类号： C07C21103
CPC分类号： C07D213/30 , A61K31/135 , A61K31/401 , A61K31/4152 , A61K31/417 , A61K31/4184 , A61K31/4402 , A61K31/4465 , A61K31/5375 , C07C217/08 , C07C217/30 , C07C217/36 , C07C217/76 , C07C217/84 , C07C255/54 , C07C2601/18 , C07C2602/10 , C07D207/09 , C07D211/26 , C07D213/38 , C07D213/65 , C07D215/20 , C07D233/56 , C07D233/64 , C07D235/06 , C07D295/13 , C07D317/54 , C07D333/16
摘要： The invention provides sodium channel modulating compounds which are useful for treating diseases or conditions associated with sodium channel activity, such as neuropathic pain. The invention also provides pharmaceutical compositions comprising a compound of the present invention, as well as therapeutic methods comprising administering such a compound or salt to a mammal (e.g. a human).
-
5.发明授权公开(公告)号：US07772239B2
公开(公告)日：2010-08-10
申请号：US11986212
申请日：2007-11-20
申请人： Roland Gendron , Seok-ki Choi , Paul R. Fatheree , Adam A. Goldblum , Daniel D. Long , Daniel Marquess , S. Derek Turner
发明人： Roland Gendron , Seok-ki Choi , Paul R. Fatheree , Adam A. Goldblum , Daniel D. Long , Daniel Marquess , S. Derek Turner
IPC分类号： A61K31/46 , A61K31/496 , A61P1/00
CPC分类号： C07D451/04 , A61K31/46 , A61K31/496
摘要： The invention provides novel benzoimidazolone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
摘要翻译： 本发明提供新的苯并咪唑酮 - 甲酰胺5-HT4受体激动剂化合物。 本发明还提供包含这些化合物的药物组合物，使用这些化合物治疗与5-HT4受体活性有关的疾病的方法，以及可用于制备这些化合物的方法和中间体。
-
公开(公告)号：US20080146807A1
公开(公告)日：2008-06-19
申请号：US12012579
申请日：2008-02-04
申请人： Daniel Marquess , Seok-Ki Choi , Paul R. Fatheree , Roland Gendron , Adam A. Goldblum , Daniel D. Long , S. Derek Turner , Jyanwei Liu
发明人： Daniel Marquess , Seok-Ki Choi , Paul R. Fatheree , Roland Gendron , Adam A. Goldblum , Daniel D. Long , S. Derek Turner , Jyanwei Liu
IPC分类号： C07D451/02
CPC分类号： G01N33/5044 , C07D451/04 , G01N33/5008 , G01N2333/70571
摘要： The invention provides novel indazole-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
摘要翻译： 本发明提供了新的吲唑 - 甲酰胺5-HT 4受体激动剂化合物。 本发明还提供包含这些化合物的药物组合物，使用这些化合物治疗与5-HT 4受体活性有关的疾病的方法，以及可用于制备这些化合物的方法和中间体。
-
公开(公告)号：US20140163063A1
公开(公告)日：2014-06-12
申请号：US14043585
申请日：2013-10-01
申请人： Daniel Marquess , Paul R. Fatheree , S. Derek Turner , Daniel D. Long , Seok-Ki Choi , Adam A. Goldblum , Daniel Genov
发明人： Daniel Marquess , Paul R. Fatheree , S. Derek Turner , Daniel D. Long , Seok-Ki Choi , Adam A. Goldblum , Daniel Genov
IPC分类号： C07D451/02
CPC分类号： C07D451/02 , C07D451/04
摘要： The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
摘要翻译： 本发明提供新的喹啉酮 - 甲酰胺5-HT 4受体激动剂化合物。 本发明还提供包含这些化合物的药物组合物，使用这些化合物治疗与5-HT4受体活性有关的疾病的方法，以及可用于制备这些化合物的方法和中间体。
-
公开(公告)号：US07875629B2
公开(公告)日：2011-01-25
申请号：US12234906
申请日：2008-09-22
申请人： Adam A. Goldblum , Seok-ki Choi , Paul R. Fatheree , Roland Gendron , Lan Jiang , Daniel D. Long , Daniel Marquess , S. Derek Turner
发明人： Adam A. Goldblum , Seok-ki Choi , Paul R. Fatheree , Roland Gendron , Lan Jiang , Daniel D. Long , Daniel Marquess , S. Derek Turner
IPC分类号： A61K31/46
CPC分类号： C07D451/04 , C07D453/02
摘要： The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
摘要翻译： 本发明提供新的喹啉酮 - 甲酰胺5-HT 4受体激动剂化合物。 本发明还提供包含这些化合物的药物组合物，使用这些化合物治疗与5-HT4受体活性有关的疾病的方法，以及可用于制备这些化合物的方法和中间体。
-
公开(公告)号：US20090209582A1
公开(公告)日：2009-08-20
申请号：US11920817
申请日：2006-05-24
申请人： Robert Murray McKinnell , Roland Gendron , Lan Jiang , Seok-ki Choi , Daniel D. Long , Paul R. Fatheree , Daniel Marquess , Sean Dalziel , Kirsten M. Phizackerley
发明人： Robert Murray McKinnell , Roland Gendron , Lan Jiang , Seok-ki Choi , Daniel D. Long , Paul R. Fatheree , Daniel Marquess , Sean Dalziel , Kirsten M. Phizackerley
IPC分类号： A61K31/4545 , C07D401/14 , A61P1/00
CPC分类号： C07D401/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , G01N33/5058
摘要： The invention relates to benzimidazole-carboxamide 5-HT4 receptor agonist compounds of formula (I) wherein R1 and X are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention also relates to pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds. The invention further relates to crystalline forms of a compound of formula (I).
摘要翻译： 本发明涉及式（I）的苯并咪唑 - 甲酰胺5-HT 4受体激动剂化合物，其中R 1和X如说明书中所定义，或其药学上可接受的盐或溶剂合物或立体异构体。 本发明还涉及包含这些化合物的药物组合物，使用这些化合物治疗与5-HT 4受体活性有关的疾病的方法，以及可用于制备这些化合物的方法和中间体。 本发明还涉及式（I）化合物的结晶形式。
-
公开(公告)号：US20080176895A1
公开(公告)日：2008-07-24
申请号：US12075669
申请日：2008-03-13
申请人： Daniel Marquess , Paul R. Fatheree , S. Derek Turner , Daniel D. Long , Seok-Ki Choi , Adam A. Goldblum , Daniel Genov
发明人： Daniel Marquess , Paul R. Fatheree , S. Derek Turner , Daniel D. Long , Seok-Ki Choi , Adam A. Goldblum , Daniel Genov
CPC分类号： C07D451/02 , C07D451/04
摘要： The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
摘要翻译： 本发明提供新颖的喹啉酮 - 甲酰胺5-HT 4受体激动剂化合物。 本发明还提供包含这些化合物的药物组合物，使用这些化合物治疗与5-HT 4受体活性相关的疾病的方法，以及可用于制备这些化合物的方法和中间体。
-
-
-
-
-
-
-
-
-
搜索结果
153 条记录 (耗时 0.04 秒)
